SCHEMBL31428552

SCHEMBL31428552

Cc1cc(-c2cccc(C(=O)OC(C)(C)C)c2)c2cc(C(=O)N3CCOCC3)ccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
HPGD P15428 1/20 0.44
PIK3CD O00329 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
ERN1 O75460 3/20 0.43
PLK4 O00444 1/20 0.42
JAK2 O60674 1/20 0.42
MAP4K4 O95819 1/20 0.42
ROS1 P08922 1/20 0.42
FGFR1 P11362 1/20 0.42
FLT1 P17948 1/20 0.42
MARK3 P27448 1/20 0.42
FLT4 P35916 1/20 0.42
KDR P35968 1/20 0.42
FLT3 P36888 1/20 0.42
CLK2 P49760 1/20 0.42
CSNK1G2 P78368 1/20 0.42
MAP4K2 Q12851 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31428610 0.91 GRM2 (0.46) MEN1KMT2AHPGDJAK2PDCD1
SCHEMBL31428549 0.89 ERN1 (0.47) MEN1RAB9AKMT2AHPGDPIK3CD
SCHEMBL24975792 0.89 ERN1 (0.47) MEN1RAB9AKMT2AHPGDPIK3CD
SCHEMBL31428979 0.85 HPGD (0.51) MEN1RAB9AKMT2AHPGDERN1
SCHEMBL24975800 0.85 KDM4E (0.46) HPGDPDCD1CD274KDM4EPKM
SCHEMBL31428793 0.85 KDM4E (0.46) HPGDPDCD1CD274KDM4EPKM
SCHEMBL31428513 0.85 PDCD1 (0.53) MEN1KMT2AHPGDPDCD1CD274
SCHEMBL24975658 0.84 NPC1 (0.44) MEN1KMT2AL3MBTL1KDM4E
SCHEMBL24976143 0.81 ABCG2 (0.46) MEN1RAB9AKMT2AL3MBTL1KDM4E
SCHEMBL31428903 0.81 ABCG2 (0.46) MEN1RAB9AKMT2AL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS MEN1 1712/4885RAB9A 67/4885KMT2A 2837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.